文献速递鼻科

新型产氧生物材料治疗慢性鼻窦炎的体外评估

In vitro evaluation of a novel oxygen-generating biomaterial for chronic rhinosinusitis therapy.
PubMed 文献 · Int Forum Allergy Rhinol · 2021-08-26

本研究开发了一种产氧生物材料(OGB),通过蜂蜡包覆过氧化钙-过氧化氢酶复合物制成,并在体外评估其氧气释放、过氧化氢生成、细胞毒性及对人气道上皮细胞氯离子分泌的影响。结果显示OGB可持续释放氧气7天,且细胞毒性降低、氯离子转运增加,提示其作为慢性鼻窦炎治疗策略的潜力。

要点

  • OGB由蜂蜡包覆过氧化钙-过氧化氢酶复合物构成,可持续释放氧气7天。
  • CPO-CA(1)-BW(1)组氧气累积释放量最高,且过氧化氢生成显著低于未包覆组。
  • OGB在体外降低细胞毒性并增加氯离子转运,支持进一步临床前研究。

核心结论

  • 新型产氧生物材料(CPO-CA-BW复合物)在体外可持续释放氧气7天,24小时后无显著细胞毒性。
  • 该材料可能成为基于阻塞性慢性鼻窦炎模型的潜在治疗策略,值得进一步临床前研究。

研究设计与样本

  • 体外实验研究,制备蜂蜡包覆的过氧化钙-过氧化氢酶复合物(OGB),并对其表征和功能进行评估。
  • 使用扫描电子显微镜表征材料,分光光度法定量氧气和过氧化氢释放,并在人气道上皮细胞中评估细胞毒性和氯离子转运。

主要发现

  • 7天内氧气累积释放量(mmol/mg):CPO-CA(1)-BW(1)为0.11 ± 0.003,CPO-CA(1)-BW(0.5)为0.08 ± 0.010,CPO为0.05 ± 0.004(p < 0.0001)。
  • 24小时后过氧化氢产量(mM):CPO组为1.87 ± 0.50,CPO-CA(1)-BW(1)组为0.00 ± 0.00(p < 0.001)。
  • 与CPO组相比,CPO-CA(1)-BW(1)组细胞毒性显著降低,氯离子转运增加。

临床怎么用

  • 该产氧生物材料可能通过缓解局部缺氧来干预慢性鼻窦炎,但目前仅为体外证据,尚未进入临床。

局限性

  • 研究为体外实验,未在动物模型或人体中验证疗效和安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypoxia due to closure at the ostiomeatal complex is widely considered one of the major pathogenic mechanisms leading to chronic inflammation in chronic rhinosinusitis (CRS). The objective of this study was to develop and characterize an oxygen-generating biomaterial (OGB) as an innovative treatment strategy for CRS. METHODS: An OGB was fabricated by coating hydrophobic beeswax (BW, 15mg or 30mg) on the surface of calcium peroxide - catalase complex (CPO-CA, 30mg) and characterized using scanning electron microscopy (SEM). In vitro releases of both oxygen and hydrogen peroxide (H2 O2 ) were spectrophotometrically quantified, and cytotoxicity in human sinonasal epithelial cells (HSNECs) was evaluated. The influence of OGB on transepithelial Cl- secretion was also determined by pharmacologically manipulating HSNECs, cultured under hypoxic conditions, in Ussing chambers. RESULTS: Three groups of OGBs: (1) CPO only; (2) CPO coated with CA and BW (1:1 ratio, CPO-CA(1)-BW(1)); and (3) CPO coated with CA and BW (1:0.5 ratio, CPO-CA(1)-BW(0.5) were analyzed for accumulated oxygen release over 7 days: highest release (mmol/mg) was observed in CPO-CA(1)-BW(1) = 0.11 ± 0.003, followed by CPO-CA(1)-BW(0.5) = 0.08 ± 0.010, and CPO = 0.05 ± 0.004 (p < 0.0001). H2 O2 production (mM) was significantly higher in CPO (1.87 ± 0.50) compared to CPO-CA (1)-BW(1) (0.00 ± 0.00) (p < 0.001) after 24 h. CPO-CA(1)-BW(1) showed significantly reduced cytotoxicity and increased Cl- transport compared to the CPO group. CONCLUSION: A novel OGB (CPO-CA-BW complex) exhibited sustained oxygen release over 7 days without significant cytotoxicity after 24 h in vitro. Preclinical studies evaluating the efficacy of OGB in CRS are warranted, especially for potential therapy in an obstruction-based CRS model.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Lim DJ, Skinner D, West JM, et al. In vitro evaluation of a novel oxygen-generating biomaterial for chronic rhinosinusitis therapy. Int Forum Allergy Rhinol. 2021. PMID: 34448372. doi:10.1002/alr.22875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。